“All of the things to everyone everywhere”: A mixed methods analysis of community perspectives on equitable access to monoclonal antibody treatment for COVID-19

<h4>Background</h4> Neutralizing monoclonal antibody (mAb) treatment for COVID-19 prevents hospitalization and death but is underused, especially in racial/ethnic minority and rural populations. Reasons for underuse and inequity may include community member lack of awareness or healthcar...

Full description

Bibliographic Details
Main Authors: Bethany M. Kwan, Chelsea Sobczak, Carol Gorman, Samantha Roberts, Vanessa Owen, Matthew K. Wynia, Adit A. Ginde, Griselda Pena-Jackson, Owen Ziegler, Lisa Ross DeCamp
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2022-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9683597/?tool=EBI